Shivani Srivastava, Shreekar Roddam, Deepshikha Srivastava, Abdulmumini Shehu, Khyathi Krishna Gogineni, Ruchit Singla, Ahmed Owolabi, Basma Alleelwa, Aliyu O Olaniyi, Olabisi P Lawal
{"title":"Exploring Non-antibiotic Interventions for Preventing Urinary Tract Infections During Pregnancy: A Systematic Review.","authors":"Shivani Srivastava, Shreekar Roddam, Deepshikha Srivastava, Abdulmumini Shehu, Khyathi Krishna Gogineni, Ruchit Singla, Ahmed Owolabi, Basma Alleelwa, Aliyu O Olaniyi, Olabisi P Lawal","doi":"10.7759/cureus.93874","DOIUrl":null,"url":null,"abstract":"<p><p>Urinary tract infections (UTIs) are a common health concern in pregnancy and often require antibiotic therapy. Antimicrobial resistance (AMR) resulting from antibiotic misuse is a major public health challenge, and non-antibiotic interventions (NAIs) may provide a safer means of prevention. This systematic review evaluated non-antibiotic strategies for preventing UTIs during pregnancy as a way to reduce antibiotic prescribing and combat AMR. The review aims to evaluate the role of NAIs in preventing UTIs during pregnancy, with a focus on their potential to reduce antibiotic prescribing and AMR within the NHS care system. A systematic search of Ovid Medline, Web of Science, and Scopus identified studies that compared NAIs to a placebo, usual treatment, or no intervention. Eligible studies included randomised controlled trials, cohort studies, and other relevant designs. Study quality was assessed using established appraisal tools, and a narrative synthesis was conducted due to intervention heterogeneity. Eight studies met the inclusion criteria, examining cranberry products, Mediterranean diet, OM-89 (an oral immunostimulant also known as Uro-Vaxom), ascorbic acid, and knowledge-based interventions. Evidence from seven studies suggests that NAIs may reduce UTI incidence, but the findings are limited, and further research is needed to confirm their effectiveness during pregnancy. The review concludes that NAIs, particularly cranberry products and the Mediterranean diet, may reduce UTI incidence during pregnancy and offer a promising strategy to limit antibiotic use and AMR. However, given the methodological limitations and low quality of available evidence, further high-quality research is required to establish the safety, efficacy, and cost-effectiveness of these therapies in pregnant women.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 10","pages":"e93874"},"PeriodicalIF":1.3000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497408/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cureus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7759/cureus.93874","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Urinary tract infections (UTIs) are a common health concern in pregnancy and often require antibiotic therapy. Antimicrobial resistance (AMR) resulting from antibiotic misuse is a major public health challenge, and non-antibiotic interventions (NAIs) may provide a safer means of prevention. This systematic review evaluated non-antibiotic strategies for preventing UTIs during pregnancy as a way to reduce antibiotic prescribing and combat AMR. The review aims to evaluate the role of NAIs in preventing UTIs during pregnancy, with a focus on their potential to reduce antibiotic prescribing and AMR within the NHS care system. A systematic search of Ovid Medline, Web of Science, and Scopus identified studies that compared NAIs to a placebo, usual treatment, or no intervention. Eligible studies included randomised controlled trials, cohort studies, and other relevant designs. Study quality was assessed using established appraisal tools, and a narrative synthesis was conducted due to intervention heterogeneity. Eight studies met the inclusion criteria, examining cranberry products, Mediterranean diet, OM-89 (an oral immunostimulant also known as Uro-Vaxom), ascorbic acid, and knowledge-based interventions. Evidence from seven studies suggests that NAIs may reduce UTI incidence, but the findings are limited, and further research is needed to confirm their effectiveness during pregnancy. The review concludes that NAIs, particularly cranberry products and the Mediterranean diet, may reduce UTI incidence during pregnancy and offer a promising strategy to limit antibiotic use and AMR. However, given the methodological limitations and low quality of available evidence, further high-quality research is required to establish the safety, efficacy, and cost-effectiveness of these therapies in pregnant women.
尿路感染(uti)是妊娠期常见的健康问题,通常需要抗生素治疗。抗生素滥用导致的抗菌素耐药性(AMR)是一项重大的公共卫生挑战,非抗生素干预措施(NAIs)可能提供更安全的预防手段。本系统综述评估了预防妊娠期尿路感染的非抗生素策略,作为减少抗生素处方和对抗抗生素耐药性的一种方式。该综述旨在评估NAIs在预防妊娠期尿路感染方面的作用,重点关注其在NHS护理系统中减少抗生素处方和抗菌素耐药性的潜力。通过对Ovid Medline、Web of Science和Scopus的系统搜索,发现了将NAIs与安慰剂、常规治疗或不干预进行比较的研究。符合条件的研究包括随机对照试验、队列研究和其他相关设计。使用已建立的评估工具评估研究质量,并由于干预异质性而进行叙事综合。8项研究符合纳入标准,检查了蔓越莓产品、地中海饮食、OM-89(口服免疫刺激剂,也称为urovaxom)、抗坏血酸和基于知识的干预措施。来自7项研究的证据表明,NAIs可能会降低尿路感染的发生率,但研究结果是有限的,需要进一步的研究来证实其在怀孕期间的有效性。该综述的结论是,NAIs,特别是蔓越莓产品和地中海饮食,可能会减少妊娠期间尿路感染的发病率,并为限制抗生素使用和抗生素耐药性提供了一个有希望的策略。然而,由于方法学的局限性和现有证据的低质量,需要进一步的高质量研究来确定这些治疗在孕妇中的安全性、有效性和成本效益。